May 25, 2026 a 07:43 am
PFE: Fundamental Ratio Analysis - Pfizer Inc.
Pfizer Inc. exhibits a strong market presence with a diversified portfolio of biopharmaceutical products. Despite current market challenges, its extensive collaboration agreements and vaccine development efforts continue to drive potential growth. Investors might consider stability from its established brands but should be cautious of the competitive healthcare sector.
Fundamental Rating
The analysis of Pfizer Inc.'s fundamental metrics suggests a stable but cautious outlook. Several key financial ratios are analyzed below, with visualization provided for clarity.
| Category | Score | Visualization |
|---|---|---|
| Discounted Cash Flow | 4 | |
| Return On Equity | 4 | |
| Return On Assets | 4 | |
| Debt To Equity | 1 | |
| Price To Earnings | 2 | |
| Price To Book | 3 |
Historical Rating
The historical fundamentals provide insight into the stability and performance trends of Pfizer Inc.
| Date | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2026-05-22 | 3 | 4 | 4 | 4 | 1 | 2 | 3 |
| Previous | 0 | 4 | 4 | 4 | 1 | 2 | 3 |
Analyst Target Prices
Analysts provide a range of target prices suggesting potential valuation directions for Pfizer Inc.
| High | Low | Median | Consensus |
|---|---|---|---|
| $30 | $25 | $27 | $26.78 |
Analyst Sentiment
The sentiment from analysts indicates a cautious but generally positive outlook, reflecting in their recommendations.
| Recommendation | Count | Visualization |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 16 | |
| Hold | 21 | |
| Sell | 2 | |
| Strong Sell | 0 |
Conclusion
Pfizer Inc.'s fundamental strength is evident in its strong return ratios despite a less favorable debt position. The diversity of its pharmaceutical products and collaboration agreements positions it well against industry risks. While the market perceives it as a 'Hold', its potential growth through innovative therapies and vaccines presents notable opportunities. However, the competitive nature in healthcare demands strategic vigilance.
Smart Data Insight
Master the Perfect Entry & Exit for this Stock
Don't leave your profits to chance. Historically, this stock follows specific seasonal patterns that institutional traders use to maximize returns.
- ✅ Identify the "Golden Buying Window"
- ✅ Avoid high-risk correction cycles
- ✅ Backtested data from the last 20+ years